Showing results (501-510 of 863) with videos related to
Sort By:
Pageof 87
Med (New York, N.Y.)|May 19, 2022
Inhibition of ketohexokinase in adults with NAFLD reduces liver fat and inflammatory markers: A randomized phase 2 trialDavid J Kazierad, Kristin Chidsey, Veena R Somayaji, et al.Med (New York, N.Y.)|February 1, 2021
A booster dose enhances immunogenicity of the COVID-19 vaccine candidate ChAdOx1 nCoV-19 in aged miceAlyssa Silva-Cayetano, William S Foster, Silvia Innocentin, et al.Med (New York, N.Y.)|February 1, 2021
Cell-free DNA tissues of origin by methylation profiling reveals significant cell, tissue, and organ-specific injury related to COVID-19 severityAlexandre Pellan Cheng, Matthew Pellan Cheng, Wei Gu, et al.Med (New York, N.Y.)|February 1, 2021
Vaccination Is the Only Acceptable Path to Herd ImmunityAngela L RasmussenMed (New York, N.Y.)|February 1, 2021
Uniting Infectious Disease and Physical Science Principles on the Importance of Face Masks for COVID-19Monica Gandhi, Linsey C MarrMed (New York, N.Y.)|February 1, 2021
Long-Term Patient-Customized Therapy for a Pathogenic EPO MutationAyesha Ejaz, Alper Ozcan, Ekrem Unal, et al.Med (New York, N.Y.)|February 12, 2021
Fatal perinatal mitochondrial cardiac failure caused by recurrent de novo duplications in the ATAD3 locusAnn E Frazier, Alison G Compton, Yoshihito Kishita, et al.Med (New York, N.Y.)|March 2, 2021
Deadly COVID-19 among the elderly: Innate immune memory helping those most in needYahya Sohrabi, Holger Reinecke, Leo A B Joosten, et al.Med (New York, N.Y.)|March 22, 2021
Identifying CNS-colonizing T cells as potential therapeutic targets to prevent progression of multiple sclerosisMax Kaufmann, Hayley Evans, Anna-Lena Schaupp, et al.Med (New York, N.Y.)|March 16, 2022
Metreleptin therapy for nonalcoholic steatohepatitis: Open-label therapy interventions in two different clinical settingsBaris Akinci, Angela Subauste, Nevin Ajluni, et al.Pageof 87